Healthcare-focused Somerset Indus Capital closes Fund III at $288-M

Somerset Indus Capital Partners has raised its third fund, Fund III, at USD 288 million, exceeding its initial target of USD 250 million. The fund received participation from a diverse group of global institutional investors, including development finance institutions (DFIs), global investment firms, domestic financial institutions, insurance companies, funds of funds, family offices, and impact investors across Europe, the US, and Southeast Asia.Somerset Indus focuses on addressing healthcare access gaps in Tier II and Tier III markets. Fund III will invest in scalable healthcare businesses providing affordable and accessible quality care across healthcare delivery, pharmaceuticals, medical devices, diagnostics, and allied sectors. The fund typically invests between USD 15 million and USD 40 million per portfolio company.